OMEGA-MATRIX
Natural health product licensed in Canada
- Other names
- Omega Matrix Marine Lipids
- Licence holder
- Cyto-Matrix Inc.
- NPN or DIN-HM
- 80021261
- Status
- Active licence
- Licence date
- 28 November 2012
- Revision date
- 31 October 2025
- Form
- Gélule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Borago officinalis L.: Les préparations de cette plante sont autorisées s'il peut être démontré qu'elles ne dépassent pas 1 ppb d'alcaloïdes pyrrolizidiniques.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de poisson Source : Clupeidae - en entier Potency : 40 % Eicosapentaenoic acid | 1,000 mg | Not calculated |
| Huile de poisson Source : Clupeidae - en entier Potency : 20 % Docosahexaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 40 % Eicosapentaenoic acid | 1,000 mg | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 20 % Docosahexaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Scombridae - en entier Potency : 40 % Eicosapentaenoic acid | 1,000 mg | Not calculated |
| Huile de poisson Source : Scombridae - en entier Potency : 20 % Docosahexaenoic acid | Not specified | Not calculated |
| Borago officinalis Source : Grain | 200 mg | Not calculated |
Non-medicinal ingredients
d-alpha tocophérol, Eau purifiée, Glycérol, Glycérine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 gel capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Provides support for the cardiovascular health. Helps to reduce serum triglycerides. Helps to support cognitive health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80021261
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.